BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28591550)

  • 1. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.
    Bartoš V; Kullová M
    Acta Medica (Hradec Kralove); 2017; 60(1):32-36. PubMed ID: 28591550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
    Bartoš V; Kullová M
    Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
    Bartoš V
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
    Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
    Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
    Bartoš V; Kullová M
    Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
    Ramdial PK; Madaree A; Reddy R; Chetty R
    J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
    Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
    J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma.
    Law AM; Oliveri CV; Pacheco-Quinto X; Horenstein MG
    J Cutan Pathol; 2003 Apr; 30(4):232-6. PubMed ID: 12680952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of beta-catenin in basal cell carcinoma.
    El-Bahrawy M; El-Masry N; Alison M; Poulsom R; Fallowfield M
    Br J Dermatol; 2003 May; 148(5):964-70. PubMed ID: 12786827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic basal cell carcinoma exhibits reduced actin expression.
    Uzquiano MC; Prieto VG; Nash JW; Ivan DS; Gong Y; Lazar AJ; Diwan AH
    Mod Pathol; 2008 May; 21(5):540-3. PubMed ID: 18223552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
    Kiely JR; Patel AJK
    J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific characteristics of skin basal cell carcinoma invasion].
    Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
    Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
    Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
    Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation.
    Marsh D; Dickinson S; Neill GW; Marshall JF; Hart IR; Thomas GJ
    Cancer Res; 2008 May; 68(9):3295-303. PubMed ID: 18451156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdc42 is involved in basal cell carcinoma carcinogenesis.
    Tucci MG; Lucarini G; Zizzi A; Rocchetti R; Brancorsini D; Di Primio R; Ricotti F; Ricotti G
    Arch Dermatol Res; 2013 Nov; 305(9):835-40. PubMed ID: 23589095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma.
    Jawhari AU; Noda M; Pignatelli M; Farthing M
    J Pathol; 1999 Oct; 189(2):180-5. PubMed ID: 10547572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin expression in basal cell carcinoma.
    Pizarro A; Benito N; Navarro P; Palacios J; Cano A; Quintanilla M; Contreras F; Gamallo C
    Br J Cancer; 1994 Jan; 69(1):157-62. PubMed ID: 8286199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.